Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyThu, 02 May 2024 06:09:32 +0200Mon, 20 Nov 2023 10:16:00 +0100Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tepmetkoHuman medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tepmetkoMon, 20 Nov 2023 10:16:00 +0100Human medicineTepmetko : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5524-en.pdfTepmetko : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5524-en.pdfMon, 20 Nov 2023 10:11:00 +0100Human medicine